3D Printing Industry review of the year: February 2020 – 3D Printing Industry

The month of February 2020 saw industry leaders come together for TV SDs 2nd Additive Manufacturing Conference, alongside 3D printing-enabled medical breakthroughs and a landmark delivery of 3D printed parts within the maritime sector.

Read on for the standout developments of February 2020, which involved the likes of Renishaw, Wilhelmsen, Formlabs, COBOD, and Evonik.

TV SDs Additive Manufacturing Conference

February got underway with the 2nd TV SD Additive Manufacturing Conference, held in the heart of Bavaria, which brought together 3D printing experts, industry leaders, and academics to share their thoughts on the implementation of industrial additive manufacturing.

During the conference, standardization and digitization were singled out as the gateways to a fully automated additive manufacturing system in years to come in regards to material testing, quality assurance, part certification, and process chains.

Space-time research expands for AM

Meanwhile, researchers from the Delft University of Technology (TU Delft) developed a method to concurrently optimize 3D printed structures and the fabrication sequence that creates them, specifically in the wire arc additive manufacturing process (WAAM).

Recently awarded the ISSMO/Springer prize from the International Society of Structural and Multidisciplinary Optimization (ISSMO), the research can be explained using the example of a robot building a bridge in a futuristic scenario, where the bridge must maintain its mechanical strength as it is being built in order to support the weight of the robot.

Wilhelmsens landmark maritime delivery

Global maritime industry group Wilhelmsen delivered what it claimed to be a landmark commercial delivery of 3D printed parts to dry bulk shipping company Berge Bulk. The delivery was part of Wilhelmsens Early Adopter Program with additive manufacturing service bureau Ivaldi Group, which was launched in late 2019 and involved the supply of 3D printed spare parts on-demand to ships and other vessels.

This is just the beginning of the journey, and we are quickly expanding our offering, together with our key development partners, enabling our customers to benefit from the savings provided by 3D printing, digital inventory and on-demand localized manufacturing, said Hakon Ellekjaer, head of venture, 3D printing, at Wilhelmsen Ships Services.

Research roadmaps and material exploration

Midway through February, a worldwide collective of researchers from various universities and institutions came together to produce a roadmap for 3D bioprinting, which was published in Biofabrication.

Summarising the current state of bioprinting, including recent advances of the technology, present developments, and challenges, the paper envisioned how the technology could improve in the future. Topics covered in the paper ranged from cell expansion and novel bio-ink development to stem cell printing and organoid-based tissue development, in addition to bioprinting human-scale tissue structures and multicellular engineered living systems.

Elsewhere, research coming out of the Tokyo University of Science explored how water molecules react when they come into contact with the surface of graphene, revealing there is much to learn about the interaction between water and 3D printed materials.

Surface water on carbon nanomaterials such as graphene has attracted much attention because the properties of these materials make them ideal for studying the microscopic structure of surface water, saidProfessor Takahiro Yamamoto, leader of the study.

Advancing dental restorations

SLA 3D printer manufacturer Formlabs announced new materials from German dental 3D printing pioneer BEGO were to be used in Formlabs Form 3B and Form 2 resin printers. Using these systems, dental professionals are now able to 3D print temporary and permanent crowns and bridges directly for patients.

Widely regarded as a specialist in the sector, BEGO has been developing dental-specific 3D printing materials for over two decades. Now, Formlabs printing systems will use BEGOs materials to print permanent single crowns, inlay, onlays, and veneers, and temporary crowns and bridges.

Construction printing: Live

Danish 3D printing construction firm COBOD demonstrated its construction technology by 3D printing the walls of small four houses during the international Bautec construction exhibition in Berlin, between 18-21 February. The demo was completed using the companys BOD2 3D construction printer, and aimed to provide an un-cut example of its technology in action to Bautec visitors.

When you print live, it is not possible to hide anything, explained Henrik Lund-Nielson, COBOD CEO. With this live printing, we are documenting that our technology has the quality, robustness and stability to perform hour after hour, day after day.

Evoniks first 3D printing software tool

Towards the latter stages of February, German specialty chemicals company Evonik launched its first software tool for 3D printing, designed to help manufacturers select the appropriate additive manufacturing process for their desired part.

Developed by Israeli start-up Castor, in which Evonik invested in late 2019, the software aids users in their choices by taking into account the designs geometry, material, and financial analysis.

Renishaw lands Parkinsons study milestone

Rounding off the month on a positive note, UK-based engineering technologies firm Renishaw announced a milestone in a medical study seeking to help sufferers of Parkinsons disease, for which it developed a patented intraparenchymal drug delivery device using 3D printing.

Initial results of the study were promising and indicated predictable and accurate placement of the neuroinfuse device, as well as significant efficacy and safety of both the device and the drug, CDNF, which was developed by pharmaceuticals experts Herantis Pharma.

Renishaw has since concluded an extension to the study, which is currently the only platform to facilitate repeated, intermittent infusions into the parenchyma, and enables patients to receive the infusions in an out-patient setting.

Subscribe to the3D Printing Industry newsletterfor the latest news in additive manufacturing. You can also stay connected by following us onTwitterand liking us onFacebook.

Be sure to subscribe to the Another Dimension podcast on your chosen podcast player to make sure you never miss an episode.

Looking for a career in additive manufacturing? Visit3D Printing Jobsfor a selection of roles in the industry.

Featured image showsFabian Meyer-Brtz, head of 3D printing at Peri, showcasing the end result for the printing on February 19, 2020. Photo via COBOD.

Follow this link:
3D Printing Industry review of the year: February 2020 - 3D Printing Industry

Paint it all Pink winner charity donation helps Elizabeth Wende Breast Care Fund – MPNnow.com

Julie Sherwood |MPNnow

Theyve been best friends for over 60 years: Cathie Donner, Lynda Lochner and Sue Simpatico. All 1969 graduates of Nazareth Academy in Rochester, the three havent let the demands of career and family stand in the way of making time for one another. That goes for a tradition started years ago of getting together on the day of their scheduled mammograms at Elizabeth Wende Breast Care.

Donner said they go out for coffee that day and its a good excuse to catch up while they stay on track with their annual breast exams.

It all changed in 2014, when Simpatico was diagnosed with lymphoma and breast cancer. Early diagnosis led to further tests, decisions about options and then treatment that included stem cell replacement, chemotherapy and a mastectomy an ordeal no one ever wants to go through.

Simpatico recovered from cancer, and her experience inspired Donner to donate the charity portion of her winnings in a national contest to the Elizabeth Wende Breast Care Fund. Created at Rochester Area Community Foundation by physicians of Elizabeth Wende Breast Care, LLC in 2008, the fund supports care, diagnostic education and research regarding breast health and cancer.

I am very grateful and thankful, said Donner, grand prize winner of Gannett Media Groups Paint it all Pink contest. Donner received a check for $5,000 and on her behalf, Gannett made a donation of $5,000 to her chosen breast cancer charity, Elizabeth Wende Breast Care Fund.

Contestants took an online quiz about breast cancer awareness. Donner, a Chili resident, said she took the quiz awhile back and didnt give it much thought afterwards. Then she learned she won, her entry having been the first chosen in the drawing.

A lot of patients have said, I am so thankful, and they wanted to do something, said Dr. Stamatia Destounis, a provider at Elizabeth Wende Breast Care in Rochester. That is what inspired the physicians of Elizabeth Wende Breast Care in 2008 to create the Elizabeth Wende Breast Care Fund at the Rochester Area Community Foundation. Dr. Destounis said that by setting up the fund through the foundation, the monies could support area organizations that promote research and education centered on breast cancer and breast health.

The Rochester Area Community Foundation, in partnership with philanthropists and community partners, works to improve the quality of life in the eight-county Rochester region through leadership and strategic grant-making.

All the monies stay in the community, said Destounis, who completed her radiology residency at the University of Rochester School of Medicine & Dentistry in 1993. She joined the Elizabeth Wende Breast Clinic and trained with its founder, Dr. Wende Logan Young, completing a breast imaging fellowship of one year and joining Elizabeth Wende Breast Clinic as an attending radiologist In July 1994.

Destounis said organizations that benefit from the fund include Breast Cancer Coalition of Rochester, the American Cancer Society, UR Medicine Wilmot Cancer Institute's Pluta Cancer Center and Embrace Your Sisters, which provides emergency breast cancer support, among others.

Elizabeth Wende Breast Care began in 1975 when Dr. Wende Logan Young opened the first dedicated breast clinic in the United States on Mt. Hope Avenue in Rochester. One of the largest freestanding breast imaging centers in the nation, it is the largest single-site breast imaging center in New York. Elizabeth Wende Breast Care states its mission has remained the same throughout the years and advances in breast imaging technology, to provide each of our patients with state-of-the art breast imaging, along with compassionate, personalized care.

Five runners up in the Paint it all Pink contest each received $500. One of the runners up is Katie Barnum of Canandaigua. Others are Geri Spera of Pueblo, Colorado; Melissa Dean of Spencer, Indiana; Judy Brazeal of Fayette, Alabama, and Kristina Schlueter of Delray Beach, Florida.

More here:
Paint it all Pink winner charity donation helps Elizabeth Wende Breast Care Fund - MPNnow.com

Platelet-Rich Plasma (PRP) Injections: Purpose & Effectiveness

You may have heard about athletes like Tiger Woods getting platelet-rich plasma (PRP) injections to help heal an injury. These shots, which are based on your own blood, are increasingly being used to treat sports injuries and to help wounds heal after surgery. Some doctors even use it as a cosmetic procedure to target signs of aging, such as wrinkles. But does it work? Heres what to keep in mind.

Plasma is the liquid part of your blood thats mostly made of water and protein. It lets red and white blood cells and platelets move through your bloodstream. Platelets are a type of blood cell that makes your blood clot. They also play a role in healing.

Doctors may use platelet-rich plasma (PRP) on injuries or damage to tendons, ligaments, muscles, joints, and skin.

To collect plasma, a doctor draws blood from your body and uses a machine to separate the platelet-rich plasma from the rest of the blood. Then the doctor numbs the area of your body being treated with PRP injections. Once youre numb, the doctor uses a needle to inject your plasma into the area of your body being treated.

For example, if youre being treated for a muscle injury, your doctor would inject plasma into several locations in that muscle. In some cases, doctors use ultrasound technology during injections to make sure theyre targeting the right area. PRP injections usually take about 30 minutes, though it depends on the area youre targeting.

Once platelets are in the area thats being treated, they break down and release growth factors, which are compounds that help cells repair and renew. This is thought to trigger your bodys healing process.

PRP injections are used to treat torn tendons, tendinitis, muscle injuries, arthritis-related pain, and joint injuries. Theyre becoming more common for cosmetic procedures, too. For example, dermatologists and hair replacement experts use PRP injections to treat a type of hair loss called androgenic alopecia, also known as male or female pattern baldness, which affects men and women. And some dermatologists provide PRP treatments for the face. (You may have heard these called a vampire facial.)

More studies are needed to see what conditions PRP can work on. So far, research shows that it speeds healing after injury or surgery for certain conditions, like torn tendons. In addition to helping injured tissue heal, some studies show PRP injections curb pain and boost mobility for people with rotator cuff injuries. PRP injections appear to reduce hair loss in people with male or female pattern baldness. But its not clear whether facial PRP injections ease visible signs of aging, like wrinkles and sagging skin.

It can take several weeks for PRP injections to start working. For some conditions, particularly those affecting the hair or the skin, it may take up to 6 months to notice the full effects. For some conditions, including hair loss, you may need to repeat the procedure to maintain the results.

Youll likely need to stop taking certain medications that thin your blood, like aspirin and ibuprofen, before you get PRP injections. You may also need to take a break from certain vitamins or supplements, such as omega-3 fatty acids. Your doctor can tell you exactly what you need to do to prepare for these shots.

PRP doesnt usually cause major side effects. But because it involves drawing blood, youll want to make sure you eat before the procedure. That will help you avoid feeling lightheaded when you get PRP injections.

After the shot, you shouldnt wash the area that was treated for 48 hours. You might notice some soreness and bruising in the area that received injections. If you feel sharp or intense pain, let your doctor know.

PRP injections may or may not be covered by your health insurance, so check your plans details. If youre getting it for cosmetic reasons -- for example, PRP injections for hair loss -- your insurance probably wont cover it. Treatment can cost $250 to $1,500 a session, and you may need several sessions to see results.

You cant get PRP injections if you have:

You should only get PRP injections from a licensed doctor.

SOURCES:

Hospital for Special Surgery: Platelet-Rich Plasma (PRP) Injection.

American Academy of Orthopaedic Surgeons: Platelet-Rich Plasma (PRP).

Johns Hopkins Medicine: Platelet-Rich Plasma (PRP).

Cedars-Sinai: Platelet Rich Plasma Therapy.

American Society of Plastic Surgeons: Platelet-Rich Plasma for Cosmetic Facial Procedures Promising Results, but Evidence Has Limitations.

American Academy of Dermatology: Is platelet-rich plasma the secret to younger-looking skin?

PLOS ONE: A Pilot Study Evaluating the Effectiveness of Platelet-Rich Plasma Therapy for Treating Degenerative Tendinopathies: A Randomized Control Trial with Synchronous Observational Cohort.

The rest is here:
Platelet-Rich Plasma (PRP) Injections: Purpose & Effectiveness

Business beat – The Spokesman-Review

UPDATED: Fri., Dec. 18, 2020

Spokane Center for Facial Plastic Surgery, a division of Columbia Surgical Specialists, has hired Brittany Martin, MSN, APRN, FNP-C. Martin graduated magna cum laude from Whitworth University and WSU College of Nursing, then completed graduate studies at Gonzaga University and graduated with honors. She is a Spokane native and worked at Columbia Surgical Specialists through her graduate studies. Martin will provide various in-office procedures, including Botox/Dysport injections, filler treatments, miraDry treatments, platelet rich plasma injections and intense-pulsed light therapy. She also will assist with post-op appointments.

Paul Merritt has been appointed as the CEO of Fatbeam, a fiber-broadband internet provider in the Coeur dAlene and Spokane areas. He has nearly 20 years experience in the telecom industry. Merritt recently served in the hyperscalers-business segment for Lumen, formerly CenturyLink, managing strategies for product and solution development and sales performance. Prior to his role at Lumen, Merritt directed all aspects of daily-sales operations for cloud, software, and infrastructure vertical teams at Zayo. He also has served as the regional vice president for Comcast Business and has held various positions with XO Communications, Qwest (CenturyLink), Redapt and Allstream.

Spokane Home Builders Association has hired Jennifer Thomas as the membership services director and Beth Hanson as office manager. Thomas previously worked with SHBAs advertising agency, QUINN, where she headed the digital advertising team. She has also been a strategist for multiple Spokane businesses. In her new role, Thomas will oversee member services, such as recruitment and retention efforts and member benefit programs. Hanson previously worked for Douglass Properties, serving nine years as a property manager and four years as the accounts payable processor, assistant to the financial controller and senior property manager. In her new role, she will handle office operations, database management and financial oversight. She will also serve as a staff liaison for the Finance and Education Committees and the Remodelers Council.

Numerica Credit Union has been honored as Outstanding Community Lender for the U.S. Small Business Administrations Seattle District, which includes all of Washington state and North Idaho. The award recognizes the community bank or credit union which closed the most standard SBA loans in the district during the SBA fiscal year, which ran from October 2019 to September . The award only measures traditional SBA 7 (a) loans, which provide assistance to small businesses. Loans and relief provided by banks and credit unions due to COVID-19 legislation, such as Paycheck Protection Program loans, were not included in the U.S. Small Business Administrations count of standard SBA loans for this award. Numerica is headquartered in Spokane Valley and has more than 158,000 members in Central and Eastern Washington and North Idaho. It manages $2.9 billion in assets.

Inland Empire Property Watch has earned accreditation from the National Home Watch Association. The NHWA is an organization that was founded in 2009 with the goal to create and maintain high-industry standards for Home Watch and absentee homeowner services throughout the United States and Canada. Home Watch is a visual inspection service for homes and other properties available to property owners who are not physically present to oversee their property. Inland Empire Property Watch is owned by John and Shari Miller who reside in Wilbur, Washington. Originally from Skagit Valley, Washington, they moved to Eastern Washington in 2012 and worked at Lake Roosevelt, where they operated the Keller Ferry and managed the Keller Ferry Marina and Campground for several years.

After meeting many seasonal residents in the area, they recently decided to open Inland Empire Property Watch.

The business serves Wilbur, Davenport, Republic, Seven Bays and Grand Coulee. Accreditation through NHWA ensures that owners and operators of Home Watch service providers have passed criminal background checks; maintain insurance coverage for general and professional liability and proper bonding; display truthful website and advertising content; and adhere to the NHWAs code of ethics and mission statement. NHWA also checks on the providers consumer complaints.

Plenty of us will be happy to see 2020 in our rear-view window come Jan. 1.

Read more:
Business beat - The Spokesman-Review

Scientists have restored youth to aging eyes in mice – Massive Science

Following the harassment of Christian Cooper in Central Park in May 2020, Black birders created #BlackBirdersWeek to celebrate Black nature enthusiasts and highlight their belonging in outdoor spaces. Since then, dozens of campaigns have emerged to amplify and appreciate Black academics, scientists, and naturalists.

Next up is #BlackInMarineScienceWeek, running from November 29th to December 5th.Led by founder Dr. Tiara Moore and organizers Amani Webber-Schultz, Dr. Camille Gaynus, Carlee Jackson, Al Troutman, Jasmin Graham, Jeanette Davis, Kris Howard, Leslie Townsell, Kaylee Arnold, and Jaida Elcock, this week represents an opportunity for community building and improved representation.

There are few Black folks in ecology and even fewer in marine ecology, says Arnold, a science communicator and disease ecologist. The network that Ive gained through organizing this week is phenomenal. Meeting other Black marine scientists and showing that to the world, especially young Black folks, is a way to say we exist, were here. We have a full day dedicated to young kids, which is unique and exciting.

The organizers hope that the week will help normalize Black folks doing marine research, inspire younger generations, and remind everyone to check their preconceived notions.

"When I say I study sharks people seem concerned about my swimming or my hair, [and] sometimes respond with 'Oh, thats super interesting'... I dont know if that's because it's unusual for people to study sharks or because Im Black and I study sharks, recalls Elcock, an elasmobranch movement ecologist, science communicator, and co-founder of Minorities in Shark Science. Science is for everybody. People say there isn't diversity because [Black] people arent interested... thats clearly not true theres a whole week dedicated [to it]."

Discussion this week will address the fact that exclusion, not lack of interest, led to todays lack of representation. Centuries of segregation and underinvestment in Black neighborhood pools led to, and are perpetuated by, these incorrect and harmful ideas.

My grandparents and my mom said there were just no pools for her to go to... I had a very different experience. Despite people trying to push us out of the water and science, we persevered, and now we get to break down those stereotypes, notes Arnold.

Black in Marine Science Week is here to do just that, showcasing organizers and participants from every imaginable marine science niche, all shaping how society views the oceans and its inhabitants.

There's more Black folks than even we know and are showcasing. I hope that if the media picks up on the number of us as well, and has better representation. Seminar series are extremely white, and now you have a resource of people you can invite instead, emphasizes Arnold, pointing to the necessity of non-Black marine scientists to step up and ensure representation continues beyond this joyous and educational week.

Here is the original post:
Scientists have restored youth to aging eyes in mice - Massive Science

Top Technical Advances of 2020 – The Scientist

COVID-19 diagnostics

A mockup of an at-home test

MAMMOTH BIOSCIENCES

Much of the world became aware of the disease now known as COVID-19 in January, and impressively, a diagnostic PCR test became available the same month. Weve since seen an explosion in potential variations on that assay, including saliva tests, which bypass the need for scarce swabs, and a slew of techniques that could be considerably faster and cheaper than PCR, including breath tests, at-home antigen tests, a diagnostic that combines loop-mediated isothermal amplification (LAMP) and CRISPR, and even an AI model that detects telltale signs of COVID-19 from CT scans.

While diagnostics gave us hard numbers on SARS-CoV-2s devastating sweep, the rapid development of vaccines against it allowed us to imagine the pandemic coming under control. mRNA vaccines from Pfizer and Moderna were among the early leaders of the vaccine race, training the spotlight on a newer technique that had been attempted for other diseases but had not yet made it to the market before 2020. The principle is to deliver a stretch of viral mRNA to recipients cells, which go on to manufacture viral proteins from the transcripts, provoking an immune response.

The year also saw researchers experimenting with other innovative ways of producing vaccines. In one examplewhich, unlike with mRNA vaccines, would avoid the need for cold temperatures during transport and storageresearchers showed that a flu vaccine delivered orally as a thin film induced an immune response in mice.

A colony of spotted wing Drosophila flies entomologist Hannah Burrack maintained at home

COURTESY HANNAH BURRACK

The pandemics effects on science were far-reaching, and necessitated adaptation as many researchers were shut out of their labs in a bid to prevent infection. Among the creative means scientists devised to continue their work was Cut&Tag@home, a protocol for profiling chromosome components that Steven Henikoff of the Fred Hutchinson Cancer Research Center devised in his laundry room.

Induced pluripotent stem cells (iPSCs) have proved a boon to research, but most labs grow the cells in expensive commercial media that require frequent tending to replenish the stock. In a paper at the start of this year, researchers described a DIY recipe for a medium with ingredients that cost a fraction of what commercial alternatives do, and that only needs to be changed every 3.5 days, enabling caretakers to have weekends off.

Neurositys Notion headset, released in 2019, is one of a handful of consumer brain-computer interface devices that scientists are adapting for their EEG research.

STEVE GONG

Collecting data on humans brain activity typically requires researchers to put their subjects into expensive MRI or PET scanners, or to affix wires to their skulls for a traditional EEG setup. But advances in brain-computer interface (BCI) technologymuch of it made with an eye toward the consumer market for devices that could be used for applications such as gaminghold the potential for neuroscientists to gather a wealth of brain activity information as subjects go about their daily activities. The field continued to advance this year with the release of two new BCI headsets, NextMind, which decodes visual attention, and the Neurosity Notion 2, an upgraded iteration of a product that, while designed for coders, can also be used to collect research data.

Read this article:
Top Technical Advances of 2020 - The Scientist

A new psychedelic drug gives psychiatric benefits without causing hallucinations – Massive Science

Following the harassment of Christian Cooper in Central Park in May 2020, Black birders created #BlackBirdersWeek to celebrate Black nature enthusiasts and highlight their belonging in outdoor spaces. Since then, dozens of campaigns have emerged to amplify and appreciate Black academics, scientists, and naturalists.

Next up is #BlackInMarineScienceWeek, running from November 29th to December 5th.Led by founder Dr. Tiara Moore and organizers Amani Webber-Schultz, Dr. Camille Gaynus, Carlee Jackson, Al Troutman, Jasmin Graham, Jeanette Davis, Kris Howard, Leslie Townsell, Kaylee Arnold, and Jaida Elcock, this week represents an opportunity for community building and improved representation.

There are few Black folks in ecology and even fewer in marine ecology, says Arnold, a science communicator and disease ecologist. The network that Ive gained through organizing this week is phenomenal. Meeting other Black marine scientists and showing that to the world, especially young Black folks, is a way to say we exist, were here. We have a full day dedicated to young kids, which is unique and exciting.

The organizers hope that the week will help normalize Black folks doing marine research, inspire younger generations, and remind everyone to check their preconceived notions.

"When I say I study sharks people seem concerned about my swimming or my hair, [and] sometimes respond with 'Oh, thats super interesting'... I dont know if that's because it's unusual for people to study sharks or because Im Black and I study sharks, recalls Elcock, an elasmobranch movement ecologist, science communicator, and co-founder of Minorities in Shark Science. Science is for everybody. People say there isn't diversity because [Black] people arent interested... thats clearly not true theres a whole week dedicated [to it]."

Discussion this week will address the fact that exclusion, not lack of interest, led to todays lack of representation. Centuries of segregation and underinvestment in Black neighborhood pools led to, and are perpetuated by, these incorrect and harmful ideas.

My grandparents and my mom said there were just no pools for her to go to... I had a very different experience. Despite people trying to push us out of the water and science, we persevered, and now we get to break down those stereotypes, notes Arnold.

Black in Marine Science Week is here to do just that, showcasing organizers and participants from every imaginable marine science niche, all shaping how society views the oceans and its inhabitants.

There's more Black folks than even we know and are showcasing. I hope that if the media picks up on the number of us as well, and has better representation. Seminar series are extremely white, and now you have a resource of people you can invite instead, emphasizes Arnold, pointing to the necessity of non-Black marine scientists to step up and ensure representation continues beyond this joyous and educational week.

Read the original here:
A new psychedelic drug gives psychiatric benefits without causing hallucinations - Massive Science

Michigans Catholic bishops say 2 COVID-19 vaccines are OK morally but another is problematic – MLive.com

GRAND RAPIDS, MI Michigans seven Catholic bishops said COVID-19 vaccines by Pfizer and Moderna are morally permissible but raised concerns about AstraZencas vaccine using a cell line that originated from tissue of an aborted fetus.

Pfizer and Moderna have received emergency approval for use by the U.S. Food and Drug Association. Pfizers vaccine has already rolled out across the country while Moderna expects to begin shipping its vaccine on Sunday, Dec. 20.

AstraZencas vaccine along with a vaccine by Johnson & Johnson - is nearing its final trial stage.

The Catholic bishops issued a statement Saturday, Dec., 19, on what they called the morality of COVID-19 vaccines.

It is morally permissible to receive the vaccines developed by Pfizer and Moderna, the bishops said.

Neither of these vaccines have used cell lines originating in tissue taken from aborted babies in their design, development, and production. However, both the Pfizer and the Moderna vaccine did use such a cell line in the confirmatory testing. This connection to the abortion is very remote, however, and it is important to keep in mind that there are varying levels of responsibility. Greater moral responsibility lies with the researchers than with those who receive the vaccine, the bishops wrote.

The vaccine developed by AstraZeneca is more morally problematic, however, the bishops wrote.

It did utilize in the design, production, development, and confirmatory testing a cell line that originated from tissue taken from an aborted baby. This vaccine may be received only if there are no other alternatives. If one does not have a choice of vaccine and a delay in immunization may bring about serious consequences for ones health and the health of others, it would be permissible to accept the AstraZeneca vaccine.

Science Magazine said that at least five COVID-19 vaccine candidates use a fetal kidney cell line from a fetus aborted around 1972 or cells of an 18-week-old fetus that was aborted in 1985.

Dr. Deepak Srivastava, former president of the International Society for Stem Cell Research, told the Associated Press that the fetal cell lines were vital in developing vaccines for a range of viruses.

They are widely used in many aspects in biomedical science because they are so effective, he said. Whats important for the public to know even if they are opposed to the use of fetal cells for therapies, these medicines that are being made and vaccines do not contain any aspect of the cells in them, Srivastava said. The cells are used as factories for production.

In a column for the Heritage Foundation, which promotes conservative public policy, Dr. Melissa Moschella said she strongly opposes abortion but supported using the cell lines derived long ago from the tissue of aborted fetuses - to develop life-saving vaccines.

Cell lines (from one of the fetuses) are far removed from the unborn child from whose tissue they were initially derived. Such cell lines are immortal, meaning that, once developed, they continue to divide and reproduce themselves indefinitely. This means that the use of such lines does not necessarily create additional demand for new fetal tissue, Moschella wrote.

The bishops said the Congregation for the Doctrine of the Faith found vaccinations permissible because of the pandemics serious health risks.

Those who do not receive vaccinations have a moral responsibility to take steps to prevent spread of the virus, they said.

At this same time, we join our voices to call for the development of vaccines that have no connection to abortion. Our consciences must not be dulled, nor may we imply in any way that abortion is acceptable, the bishops said.

The statement was issued by Allen H. Vigneron, archbishop of Detroit, and bishops Paul J. Bradley of Kalamazoo; Earl A. Boyea of Lansing; John F. Doerfler of Marquette; Robert D. Gruss of Saginaw; Walter A. Hurley, apostolic administrator, of Gaylord; and David J. Walkowiak of Grand Rapids.

Read more:

Michigan Senate approves $465M for coronavirus response, relief for businesses and unemployed workers

US clears Moderna vaccine for COVID-19, 2nd shot in arsenal

General apologizes for COVID-19 vaccine distribution day after Whitmer blasts Trump administration

See the original post:
Michigans Catholic bishops say 2 COVID-19 vaccines are OK morally but another is problematic - MLive.com

How Researchers Are Making Do in the Time of COVID-19 – The Wire Science

Image: UN/Unsplash.

One of the astonishing aspects of the human response to the COVID-19 pandemic has been how quickly scientists pivoted to studying every facet of the virus in order to mitigate the loss of life and plan for a return to normalcy. At the same time, a lot of non-coronavirus research ground to a near halt.

With research labs and offices shuttered for all but essential workers, many scientists were stuck at home, their fieldwork and meetings canceled and planned experiments kicked down the road as they struggled to figure out how to keep their research programs going. Many took the opportunity to catch up on writing grants and papers; some in between caring for kids came up with strategic workarounds to keep the scientific juices flowing.

To gauge how researchers in different fields are managing,Knowable Magazine spoke with an array of scientists and technical staff among them a specialist keeping alive genetically important strains of fruit flies, the maintenance chief of an astronomical observatory working to keep telescopes safe and on standby during the lockdown, and a paediatrician struggling to manage clinical trials for a rare genetic disease. Here are a few slices of scientific life during the pandemic.

Agnieszka Czechowicz, Stanford University School of Medicine

Czechowicz is a paediatrician in Stanfords division of stem cell transplantation and regenerative medicine, where she manages a research group that develops new therapies and conducts clinical trials on rare genetic diseases.

Agnieszka Czechowiczs father suffers from severe Parkinsons disease. The coronavirus pandemic forced him to remain indoors and away from people, robbing him of the physical conditioning and social interactions he needs to cope with his disease. A recent fall left him in the hospital, bringing the additional worry that he might contract COVID-19 there and isolating him further.

For Czechowicz, his situation brought into sharp relief the challenges the coronavirus has forced upon those carrying out clinical trials, including those she is running, which involve patients traveling to hospitals around the country. Would I have him travel to any clinical site right now for a new Parkinsons treatment? she says. Absolutely not.

The pandemic forced Czechowicz to halt clinical trials she oversees for a rare genetic disease of children called Fanconi anAemia, a condition that impairs the bodys ability to repair damaged DNA and often leads to bone marrow failure and cancer. The treatment Czechowicz and colleagues are testing involves extracting blood-forming stem cells from the patients bone marrow, inserting a healthy copy of a missing or malfunctioning gene and then reinfusing those cells back into the patient.

Every aspect of what I do is massively impacted by the pandemic, Czechowicz says. One of her early-stage clinical trials involves testing the safety of the therapy. But during the initial shutdown which started in mid-March and lasted for two months her patients could not readily travel to Stanford for the necessary follow-up visits, and remote monitoring was difficult.

Theres special blood testing and bone marrow testing that we need to do. In particular, its critical to get the samples to make sure the patients, for example, arent developing leukAemia, she says. Theres no way to know that without really checking the bone marrow. She had to clear large hurdles to get her patients evaluated.

Another early-stage trial, designed to determine the effectiveness of the therapy, also had to stop enrolling new patients. Because speed is important when it comes to treating Fanconi anaemia the children are likely losing stem cells all the time any delay in treatment can be a source of great anxiety for their parents. Czechowicz had to explain to them why the trials were temporarily halted. It was really challenging to have these discussions with the families, she says.

With the easing of travel and workplace restrictions, the families began traveling to Stanford in June but with infections back on the rise, many families are becoming hesitant again, says Czechowicz. Fortunately, her trials are small, so she can guide each family through the process of safely resuming the trials and continuing with follow-up. Her own team also has to follow strict safety protocols. For example, even though her lab has 10 members, only two can be in the lab at any one time, and only one parent is allowed into the clinic with the child.

Not all clinical trials can pay such close attention to individual patients. Large trials with hundreds of patients can involve multiple sites and require much more monitoring, so resuming those remains difficult. Also, restrictions on working full bore are slowing the pipeline for new therapies. The impact of that, were not going to see for many years to come, Czechowicz says.

Abolhassan Jawahery, University of Maryland, College Park

Jawahery is a particle physicist and a member of LHCb, one of the main experiments at the Large Hadron Collider (LHC) at CERN, the particle physics laboratory near Geneva.

In December 2018, well before the coronavirus pandemic began, the LHC shut down for upgrades. Housed in a 27-kilometre-long tunnel about 100 meters underground, the LHC accelerates two beams of protons, one clockwise and one counterclockwise, and makes them collide head-on at four locations. There, four gigantic subterranean detectors ATLAS, CMS, LHCb and ALICE sift through the debris of particles created by the collisions, looking for evidence of new physics. (For example, ATLAS and CMS found the Higgs boson, the fundamental particle of the Higgs field, which gives all elementary particles their mass.)

For its next set of experiments, which aim to probe the properties of subatomic particles with greater precision, the LHC needed to increase the intensity of its proton beams. Consequently, the four detectors needed to be upgraded too, to handle the resultant higher temperatures and increased radiation at the sites of the particle collisions. The work was on track for a restart around May 2021 until the pandemic swept all the scientists careful plans away.

The LHC and its four detectors are each run by a separate collaboration. CERN, which manages the LHC, is hopeful it can restart the collider by February 2022. They think that they can get the accelerator going if there are no more major catastrophic events, says physicist Abolhassan Jawahery. But the impact on the four detectors is less clear.

For the LHCb upgrade, Jawaherys team at the University of Maryland had been working on building about 4,000 extremely sensitive electronic circuit boards. These boards have to be burned in before they can be sent to CERN. We put them in an oven, literally cooking the boards and then running extensive tests in order to get them ready so that we can put them in the accelerator and run them for 10 to 20 years, says Jawahery. And none of that could be done during the pandemic shutdown.

The team resumed its work in June, but with restrictions put in place by the state of Maryland. Jawahery runs two labs, and for months was allowed only two people at a time in one lab and three in the other, making progress extremely slow. Still, his team is fortunate that it does not depend on supplies from countries hit hard by the coronavirus. Other labs werent so lucky. Scientists in Milan, for example, built some electronics and detector components for the LHCb, and a lab at Syracuse University in New York built sensors that relied on shipments from Milan. When Milan was completely closed down at the height of the pandemic, Syracuse, too, stopped working on Milan-dependent components.

For Jawahery the lockdown had a silver lining. The LHCs most recent run had produced about 25 gigabytes of data per second but his team had found little time to analyse any of it before the pandemic. We were complaining that we were spending all our time building the new instrument and the data keeps on coming, he says. When he and his team were locked out of their labs, they turned to their data backlog. We could do actual physics, he says. We are already getting ready to publish some papers.

Gordon Gray, Princeton University

Gray is a professionalDrosophila specialist in the department of molecular biology.

Gordon Gray has been called the chef de cuisine of Princetons fly kitchen, where he has been feeding flies for 46 years. He concocts meals for millions of fruit flies, at least 150 litres each week. When the pandemic hit in March and universities around the world shut down, Princeton deemed Grays work an essential service: The Drosophilafruit flies could not be allowed to die off.

Princetons flies include mutant and transgenic strains everything from ones that allow researchers to study the genes that influence normal development of a fly embryos organs, to those that have cancer-causing mutations. If the flies starved, researchers would need months or years to recreate these strains, says Princeton molecular biologist Elizabeth Gavis. And often, as techniques in molecular biology improve, the biologists reexamine flies they had studied earlier to get a more fine-grained understanding, making it worthwhile to preserve the strains.

Normally, if a lab had to shut down, researchers would send their flies to stock centres, such as one at Bowling Green State University in Ohio, that preserve the flies as part of their genetic library. But the stock centres couldnt handle Princetons flies, so Gray found himself on his own. Its basically catch as catch can with regards to the various labs here, just to keep things operational, he says.

For months, university pandemic restrictions have allowed only one person to be in Grays kitchen at a time. This has caused problems. Before the pandemic began, Gray, who is in his late 60s, had started training someone as a backup. But because of the one-person restriction, Gray and his trainee havent been able to work together. Gray envisions doing so soon, while wearing masks, keeping nearly 12 feet apart and communicating using hand signals.

To whip up a batch of fly food, or media, Gray uses a 50-litre steel cauldron, to which is attached a mixer that looks like an outboard motor. Gray fills the cauldron with water and adds agar, sugars, yeasts, salts and cornmeal, then brings it to a boil, all the while stirring watchfully. You dont want it to boil over, because when it does you wind up with a gigantic pancake on the floor, which you have to scoop up immediately because it gels, he says. Once the suspension cools to the right temperature, Gray adds an acid to inhibit mould, then dispenses precise amounts of the media into bottles and vials.

Even before the pandemic, Grays kitchen was isolated, to keep errant fruit flies from contaminating the pristine media. But at least he could work regular hours, because he knew the rhythms of the 10 or so fly labs he cooked for. That has changed. Labs, restricted to two occupants at a time, are now working seven days a week on rotating shifts. Gray comes in to work at all hours, because he cannot predict when each batch of fly food will run out and hell need to cook more.

He tries to work mostly at night to avoid coming into contact with others. But he still worries for his health, given his asthma and age-related risk. The relentless pandemic is taking a toll. Its exhausting, he says. It doesnt help not knowing when we will return to a sense of normalcy.

Celeste Kidd, University of California, Berkeley

Kidd is a child developmental psychologist who uses behavioural tests and computational methods to understand how children acquire knowledge.

When UC Berkeley locked down in March, Celeste Kidd found herself closeted at home, dealing simultaneously with virtual meetings and her three-year-old son. During the early days of the pandemic, Kidd kept a supply of treats handy, and when her toddler came up to her during a meeting shed sneak him some under the desk. But she hadnt accounted for how long the pandemic would last. It turns out thats not a good strategy, long term, she says. I was very literally rewarding him for bad behaviour.

Kidds son soon learned that acting up during her meetings meant more candy. I knew that would happen. I did it anyway because I didnt have the bandwidth to come up with a better solution, she says. But Kidd knew from her own research that children are also extremely flexible and can unlearn behaviours. Eventually, she had a chat with her son. First, she admitted to him that she had made a mistake by giving him candy when he disrupted her meetings, and that was bad of her. Then she brought in new rules: no candy for misbehaving and misbehaviour could even mean no treats for the rest of day. We had some meltdown moments, says Kidd. But he gets it now and he doesnt do those things.

Her son may be the only child Kidd gets to interact with during the pandemic. Thats a huge loss for her research, because the bulk of her work focuses on young children. In normal times, families would bring their children to her lab, where her research team would track their gaze as they watched videos. In one study, for example, infants about seven to nine months old would look away (demonstrating lack of interest) when the events in the video were either too complex or too simple, suggesting that infants use their cognitive resources for stimuli that have just the right amount of information.

Such work, of course, requires the presence of parent, child and researchers, all in the same room. None of that is going to happen anytime soon, she says. Those families are not going to feel comfortable coming in for a while.

Kidd is also concerned about the impact of the pandemic on younger scientists. One of her undergraduate students had spent six months working on a study aimed at exploring the complexity of kids play patterns using physical objects and their relation to working memory and other cognitive resources. The university had approved the protocol, but shelter-in-place orders went into effect the week the first child was to come for the experiment. I feel so bad for her as a young scientist, to have done all this hard work and then right when you get to the fun part, which is collecting the data and finding out if her ideas have lasting merit, she doesnt get to do that part, Kidd says.

The situation might be even worse for grad students and postdocs. All of them are experiencing a big blow to morale in general, because there is so much uncertainty about what the future holds, she says. University budget cuts mean fewer slots for graduate students and fewer jobs for postdocs. Its very hard to stay motivated and get things done when youre not sure if there will be a payoff in the future, says Kidd. Thats literally a study that we ran in the lab so were all acutely aware of it.

Maxime Boccas, ESO Paranal Observatory

Boccas is the head of maintenance, support and engineering at the European Southern Observatorys Paranal Observatory in Chile.

When the massive domes of the Very Large Telescope, a constellation of four 8-meter-class telescopes atop Mount Paranal in Chiles Atacama Desert, open to the night sky each evening and the telescopes get ready for observations, its like a dragon waking up.

When the pandemic hit in March, the dragon on Mount Paranal closed its eyes to the cosmos and slept the first shutdown in its 20-year history, which included a major earthquake in 2010 that paralyzed much of the rest of Chile. For those who had to leave Paranal, it was like being sent away from home. We spend 40% of our life here, says Maxime Boccas, who oversaw the process of ensuring an orderly shutdown of the sites scientific and technical facilities. We work and sleep here, and we stay here eight days in a row. Some of Boccass colleagues have been doing that for 20 to 25 years. Leaving Paranal was like leaving their second home. That was a weird feeling.

The skeleton staff just 20 of the normal 150 or so people remained on site kept the observatory safe, ensuring that essential systems continued working: computers that astronomers were accessing remotely, the fire detection system and the earthquake protection system essential for protecting the 8-meter-wide primary mirrors from Chiles frequent quakes. The mirrors will likely never be made again, says Boccas. All the factories that cast and polished them are dismantled. If we lost a mirror, it would take between 5 and 10 years to build up the factory again and fabricate it. So each mirror has an airbag a tube that inflates around it when the system detects tremors and other protections.

During the shutdown, astronomers kept their fingers crossed. They were anxious that no big thing, like a supernova in our galaxy, would explode, Boccas says. The heavens have been quiet, but the six-month shutdown harmed research that involves continuously monitoring the same patch of the sky for transient phenomena such as gamma ray bursts. It creates a hole in their science program, says Boccas.

The observatory began a slow return to normalcy on September 9. Boccas is overseeing the reawakening of each telescope, one at a time. The staff still less than full strength is now working in shifts that have doubled from 8 to 15 days to limit the amount of travel to and from the site. The four large telescopes are now up and running again, and Boccas hopes they will be back to working together as one by the end of January.

Boccas, his crew and a few lucky astronomers are glad to be back at Paranal. It really feels like a family and I think everyone has noticed that, he says. Even in the kitchen, they have to cook for 30 people instead of 150, so the quality of the food is different, its slightly better.

But even as people return to the observatory, Boccas worries about long-term effects of the shutdown. Given the reduced staff, he has had to cut down on the frequency of preventive maintenance tasks, such as changing belts and lubricating motors, potentially shortening the lifetime of some components. We will not know until six months, a year or three years from now, he says.

This article is part ofReset: The Science of Crisis & Recovery, an ongoing series exploring how the world is navigating the coronavirus pandemic, its consequences and the way forward. Reset is supported by a grant from the Alfred P. Sloan Foundation.

Anil Ananthaswamy is a science journalist who enjoys writing about cosmology, consciousness and climate change. Hes a 2019-20 MIT Knight Science Journalism fellow. His latest book is Through Two Doors at Once. http://www.anilananthaswamy.com.

This article originally appeared in Knowable Magazine, an independent journalistic endeavour from Annual Reviews.

Go here to read the rest:
How Researchers Are Making Do in the Time of COVID-19 - The Wire Science

Real-time observation helpful in Stem cell for vascular diseases: Study – Hindustan Times

A study has found out that Stem cell treatment for vascular diseases can be predicted through real time observation.(ANI)

A recent study has found out that Stem cell treatment for vascular diseases can be predicted through real-time observation.

In the study which was published in the journal Biomaterials, therapeutic efficacy prediction was done using initial distribution images of stem cells that differentiate to endothelial cells. It can be applied to research in the field of stem cell treatments for blood vessel regeneration.

In recent years, the number of high-risk groups for ischemic diseases such as critical limb ischemia where tissues of the toe may decay is increasing due to an increase in the number of people with obesity, diabetes, and hypertension which are triggered by changes in dietary habits, smoking and consumption of alcohol. A number of studies are actively conducted on endothelial progenitor cells (hEPCs), which are stem cells that contribute to the blood vessel regeneration in the ischemic tissues, to treat such ischemia diseases.

Vascular hEPCs migrate to regions requiring angiogenesis, such as ischemic regions, and then differentiate into endothelial cells of blood vessels or release growth factors that help the formation of blood vessels to induce regeneration of the damaged blood vessels. Hence, these cells can be developed into stem cell therapy for diseases related to blood vessels including ischemic diseases.

However, when the hEPCs with outstanding blood vessel regeneration capability are used as stem cell therapy in ischemic diseases, the therapeutic treatment efficacy may differ depending on various variables such as survival of the transplanted cells and migration to the treatment region. Accordingly, treatments for ischemic diseases are remaining in the clinical stage without being commercialized due to the limitations in accurately observing and predicting the therapeutic efficacy.

The Korea Institute of Science and Technology (KIST) recently announced that the collaborative research team led by Dr. Kwangmeyung Kim from Center for Theragnosis and Sung-Hwan Moon from Stem Cell Research Institute, T&R Biofab Co. Ltd developed a method that can predict the therapeutic efficacy based on the distribution of the initial transplantation of hEPCs by tracking the initial distribution and migration of the transplanted cells using fluorescence romographic images.

The KIST research team first enabled observing fluorescence signals through fluorescence molecular tomography by binding fluorescent dyes to the surface of hEPCs. Subsequently, the team transplanted the cells into the hind limb of mouse with severe limb ischemia and tracked them through images for 28 days to evaluate the cell movement in the body; then, tracked and observed the regeneration process of the blood flow through laser scanning microscope (Laser Doppler imaging). As a result, it was revealed that the hEPCs migrate to the damaged tissues where the ischemic disease is found.

Additionally, the shapes of cell clusters were observed to be injected into two different shapes as a result of analyzing the images of hEPCs during the initial transplantation of cell therapy treatment. The two shapes were condensed round shape and spread shape. When the therapeutic efficacy was observed by classifying the experimental groups into these two shapes, it was found that the initial condensed round shape cells migrated better and showed superior therapeutic efficacy in the experimental groups. Based on these findings, the research team predicted that the treatment efficacy will be superior when the treatment cells are formed into a condensed round shape during the initial treatment.

Our developed technology, which can quickly and accurately monitor the initial transplantation forms and changes of stem cell therapy, will enable predicting the efficacy of the transplanted hEPCs in the early stages of ischemic disease treatments, and we expect it to be used in the development of stem cell therapy treatments for ischemic diseases in the future, said Dr. Kwangmeyung Kim at KIST, who led the research.

(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)

Follow more stories on Facebook and Twitter

Link:
Real-time observation helpful in Stem cell for vascular diseases: Study - Hindustan Times